This Type of RAW HONEY Kills Every Kind of Bacteria Scientists Could Throw At It (Even the Super-Bugs!)

THIS Type of RAW HONEY Kills Every Kind of Bacteria Scientists Could Throw At It (Even the Super-Bugs!)

 by Healthy Holistic Living

The health benefits of raw, unprocessed honey are well known, but in Australia, scientists recently made a startling discovery – that one particular, obscure type of honey is capable of killing just about everything scientists throw at it, including some of the worst bacteria known to man.

 The findings were published in the European Journal of Clinical Microbiology and Infectious Diseases (June 2009 edition), and could hold special significance at a time when many of the world’s top antibiotics are failing, especially against resistant “superbugs.”
The honey in question is known as manuka honey, which is produced in New Zealand and also goes by the name of jelly bush honey.

The honey has become so popular in the past few years that shortages have been reported and fake products have been sold, leading New Zealand manuka producers to seek trademark protection (similar to French champagne or Scottish whiskey for example). It’s easy to see why now that the secret is out about this honey’s incredible health benefits.

Manuka Honey Kills MRSA, Other Superbugs 

Manuka honey is created by bees foraging on the nectar of Leptospermum Scoparium, the New Zealand manuka bush, as well as tea trees native only to Australia and New Zealand.
In the aforementioned studies, Australian researchers found that the honey killed every bacteria or pathogen it was tested on, according to a report by The Australian. The honey can be applied topically to help fight against infections of the skin, cuts and insect bites, or taken internally.


The most exciting difference with the manuka honey that was tested is that none of superbugs killed by the honey were able to build up immunity, a common problem with today’s antibiotics.
“New antibiotics tend to have short shelf lives, as the bacteria they attack quickly become resistant,” said Dr. Dee Carter of the University of Sydney’s School of Molecular and Microbial Biosciences. “Many large pharmaceutical companies have abandoned antibiotic production because of the difficulty of recovering costs. Developing effective alternatives could therefore save many lives.”